Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatm... Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriasis . The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0003 | 0.0003 | 0.0003 | 6700 | 0.0003 | CS |
| 4 | 0.000299 | 29900 | 1.0E-6 | 0.0003 | 1.0E-6 | 3560 | 0.00028236 | CS |
| 12 | 0.0002 | 200 | 0.0001 | 0.0003 | 1.0E-6 | 2014 | 0.00014501 | CS |
| 26 | 0.0002 | 200 | 0.0001 | 0.0005 | 1.0E-6 | 2939 | 0.00023082 | CS |
| 52 | -0.0002 | -40 | 0.0005 | 0.0006 | 1.0E-6 | 3914 | 0.00039698 | CS |
| 156 | -0.1602 | -99.8130841121 | 0.1605 | 0.2475 | 1.0E-6 | 33230 | 0.04856964 | CS |
| 260 | -0.1602 | -99.8130841121 | 0.1605 | 0.2475 | 1.0E-6 | 33230 | 0.04856964 | CS |
CIronman
4分前
Doc logic
4分前
Cornerstone_Marketing
4分前
TightCoil
4分前
cottonisking
6分前
Cornerstone_Marketing
6分前
Prudent Capitalist
6分前
kegstackz
7分前
Cornerstone_Marketing
7分前
Cornerstone_Marketing
8分前
doccjc
8分前
Cornerstone_Marketing
8分前
bbotcs
8分前
rbb
9分前
gfp927z
9分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。